Riskpilot← Back to searchSign inGet full accessHHS Skandinaviska AB
ABActiveOrg 5591053854Magasinsgatan 1Manufacture of other chemical products n.e.c. · NACE 2059Est. 20172 employees
Revenue 2025
SEK 18,7M
+7% vs 2024
EBITDA margin
10.9%
+29% vs 2024
Equity ratio
41.3%
Financial strength
Net profit 2025
SEK 1,3M
+39% vs 2024
| Revenue | SEK 18,7M | +7% |
| EBITDA | SEK 2M | +29% |
| Net profit | SEK 1,3M | +39% |
| Total assets | SEK 7,6M | +20% |
| Equity | SEK 3,1M | +27% |
| Employees | 2 | — |
Legal name
HHS Skandinaviska AB
Org number
5591053854
Legal form
Aktiebolag
NACE code
2059 · Manufacture of other chemical products n.e.c.
Founded
20 mars 2017
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att sälja appliceringssystem huvudsakligen bestående av limtankar, limtunnor med pumpsystem, limpistoler och datorstyrda kontrollsystem för sådana appliceringar samt för nämnda system utföra reparation, service, konsultation och utvecklingsarbete och därmed förenlig verksamhet.
Address
Magasinsgatan 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 15 617 | 18 135 | 13 223 | 17 485 | 18 735 |
| Staff expenses | — | — | — | −1 939 | −2 204 |
| EBITDA | 1 248 | 1 032 | 648 | 1 586 | 2 044 |
| Depreciation & amort. | −37 | −45 | −58 | −17 | −13 |
| EBIT | 1 211 | 987 | 590 | 1 569 | 2 031 |
| Net financials | −8 | −8 | −9 | −8 | −9 |
| Profit before tax | 897 | 722 | 473 | 1 222 | 1 616 |
| Tax | −194 | −155 | −74 | −309 | −350 |
| Net profit | 703 | 567 | 399 | 913 | 1 267 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 996 | 6 040 | 4 793 | 6 290 | 7 553 |
| Equity | 1 426 | 1 743 | 1 842 | 2 454 | 3 121 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 1 830 | 3 301 | 1 846 | 2 391 | 2 581 |
| Total debt | 1 830 | 3 301 | 1 846 | 2 391 | 2 581 |
EBITDA margin
10.9%
This company
15.8%
Market median
-31% vs market
20212025
Equity ratio
41.3%
This company
38.2%
Market median
+8% vs market
20212025
Return on equity
40.6%
This company
18.4%
Market median
+121% vs market
20212025
Net profit margin
6.8%
This company
8.1%
Market median
-16% vs market
20212025
Asset turnover
2.48×
This company
1.12×
Market median
+121% vs market
20212025
Debt / equity
1.42×
This company
0.62×
Market median
-129% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MR Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HHS Skandinaviska AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Robin Kastrup | Audit | 0 companies |
| Istvan Nagy | Board of Directors | 0 companies |
| Simon Joel Hallberg | Deputy Board Member | 0 companies |